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Background: Expression of the fructose transporter gene SLC2A5 and histone acetylation in the tran-
scribed region are induced by differentiation associated-signals such as glucocorticoids and p44/42
mitogen-activated protein kinase (MAPK) inhibition in small intestinal Caco-2 cells.
Methods: We co-treated with glucocorticoid receptor agonist dexamethasone (Dex) and p44/42 MAPK
inhibitor PD98059 (PD) in Caco-2 cells with or without Brd4 small hairpin (sh) RNA expression vector,
and the cells were analyzed by qRT-PCR and chromatin immunoprecipitation assays. The small intestine
of wild-type mice and Brd4þ / mice during weaning period were analyzed by qRT-PCR.
Results: Co-treatment with Dex and PD increased binding of the bromodomain-containing protein-4
(Brd4)–positive transcriptional elongation factor-b (P-TEFb)–RNA polymerase II complex to acetylated
histones in the transcribed region of SLC2A5. Brd4-protein depletion by shRNA revealed that the asso-
ciation of these proteins on the transcribed region of SLC2A5 promoted gene expression in a Brd4-de-
pendent manner. Expression of small-intestine Slc2a5, but not another intestinal gene sucrase-iso-
maltase, during weaning period, was signiﬁcantly lower in Brd4þ / mice compared with wild-type mice.
Conclusions: Brd4-P-TEFb plays a crucial role in differentiation-associated transcription of SLC2A5 gene in
intestinal Caco-2 cells and in the small intestine of mice during weaning period.
General signiﬁcance: Histone acetylation and the transcription elongation factor Brd4 are important for
SLC2A5 expression in the small intestine.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Stem cells in the crypt of the small intestine rapidly differ-
entiates to absorptive cells in the villus, and start to express many
genes related digestion and absorption of nutrients. Indeed, pre-
vious studies, including our own, have shown that the expression of
the hexose transporter, SLC2A5, generally called as glucose trans-
porter 5 (GLUT5), which is involved in fructose absorption from the
lumen, is induced during the transition from the crypt to the villus
[1]. It is known that glucocorticoids and inactivation of p44/42
mitogen-activated protein kinase (MAPK), also known asr B.V. This is an open access article
ional Sciences, Department of
nd Environmental Sciences,
manashi 400-8510, Japan.
ochizuki).extracellular signal-regulated kinase (ERK)1/2, play important roles
in intestinal differentiation and gene expression [2]. Expression of
the Slc2a5 gene was increased when serum concentrations of cor-
ticosterone were elevated during weaning in rats [3]. Injection of
the glucocorticoid receptor agonist dexamethasone (Dex) into
suckling rats induced the expression of small-intestine Slc2a5 [4].
p44/42 MAPK was inactivated prior to differentiation of the fetal
small intestine in rats and in human intestinal Caco-2 cells [5].
Furthermore, endogenous levels of epidermal growth factor, which
activates p44/42 MAPK, were decreased in the rat small intestine
during weaning, because it is provided via the mother's milk [3].
Inhibition of p44/42 MAPK was recently shown to enhance gluco-
corticoid-mediated SLC2A5 expression in human intestinal Caco-2
cells [6]. These evidences suggest that glucocorticoids and p44/42
MAPK inactivation could coordinately enhance SLC2A5 expression
in small-intestine cells during the differentiation.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sion, which frequently occurs in differentiating cells, is mediated
by epigenetic memories which are acquired modiﬁcations on the
chromatin such as modiﬁcations of the histone tail, including
acetylation, methylation and phosphorylation, and the DNA me-
thylation [7]. Acetylation of histones H3 and H4 is associated with
the euchromatin region and transactivation [8]. We previously
demonstrated that co-treatment of Caco-2 cells with Dex and
PD98059 (PD), which inhibits p44/42 MAPK activation, enhanced
the acetylation of histones H3 and H4 around SLC2A5, particularly
in the transcribed region of the gene [9]. These results suggest
that, under these conditions, induction of SLC2A5 expression is
regulated not only by activation of glucocorticoid receptors (GRs),
but also by enhancing the histone acetylation on SLC2A5.
Acetylation of histones H3 and H4 in the promoter region of
genes facilitates binding of the transcriptional machinery, includ-
ing transcription factors, co-activators, the SWItch/Sucrose
NonFermentable (SWI/SNF) complex, and RNA polymerase II [10].
However, the signiﬁcance of histone acetylation in transcribed
regions remains poorly understood. Bromodomain-containing
protein-4 (Brd4), which binds acetylated histones, was recently
shown to enhance gene expression by recruiting the mRNA tran-
scription elongation complex to acetylated histones in transcribed
regions of genes [11,12]. This complex, known as positive tran-
scription elongation factor-b (P-TEFb), is a heterodimer of cyclin
T1–Cdk9. These results indicate that Brd4 regulates transcription
elongation by recruiting P-TEFb to the transcribed region of genes.
Brd4 is the only bromodomain-containing protein known to re-
cruit P-TEFb to acetylated histones in transcribed regions. Brd4 is
also highly expressed in the small intestine [13], and histone
acetylation in the transcribed region of SLC2A5 was enhanced by
co-treatment with PD and Dex in Caco-2 cells [9]. However,
whether functional genes, including SLC2A5, are regulated by
Brd4-P–TEFb in differentiated cells has not yet been elucidated.
In this study, we examined the possible function of Brd4
downstream of glucocorticoids and p44/42 MAPK inhibition in
regulating SLC2A5 expression in Caco-2 cells. We also investigated
the role of Brd4 in SLC2A5 induction in the small intestine during
the suckling–weaning transition using Brd4 heterogeneous gene
targeting in mice. Our results in current study suggest that epi-
genetic regulation via histone acetylation and the Brd4 play vital
roles in induction of SLC2A5 expression during the intestinal
differentiation.2. Materials and methods
2.1. Cell culture
Caco-2 cells (American Type Culture Collection, Rockville, MD,
USA) were seeded at a density of 0.6104 cells/cm2 in 10-cm
culture collagen plates (Iwaki, Tokyo, Japan) in Dulbecco's Mod-
iﬁed Eagle's Medium (DMEM) containing 10% fetal calf serum
(FCS), 1% non-essential amino acids (Invitrogen, Carlsbad, CA,
USA), 20 mM HEPES (pH 7.4), 1 antibiotic–antimycotic mixed
stock solution (Nakaraitesk, Kyoto, Japan), and 2 mM L-glutamate
(Invitrogen) at 37 °C in a humidiﬁed atmosphere of 5% CO2.
Control short hairpin (sh) RNA- or Brd4-shRNA-expressing Caco-2
cells were constructed by inserting control or Brd4 shRNA into
the pSUPERRNAi vector (Oligoengine, Seattle, WA, USA) [14]. The
Brd4 shRNA sequence was: 5′-GATCCCCGAAAAGAGGAAGTGGAAGA-
GATTCAAGAGATCTCTTCCACTTCCTCTTTCTTTTTA-3′, and the control
shRNA sequence was: 5′-GATCCCCATGCACGTGCACATATCCCTTCAA-
GAGAGGGATATGTGCACGTGCATTTTTTGGAAA-3′. These constructs
were separately transfected with the plasmid vectors pGag-pol and
pAmpho into HEK293T packaging cells, and the supernatants werecollected as virus-containing medium 2 days after transfection. Cells
were transfected with virus-containing medium mixed with 6 μg
polybrene by centrifugation (1000g) for 2 h. Transfected cells were
selected with puromycin (Sigma Aldrich, St. Louis, MO, USA) for
7 days and cultured in the same conditions described above. After
2 days, cells had reached approximately 70% conﬂuence and normal
Caco-2 and control/Brd4-shRNA-expressing cells were continuously
cultured in DMEM containing 10% FCS stripped of glucocorticoids by
treatment with charcoal/dextran, with 1 mM Dex (glucocorticoid re-
ceptor agonist) and 50 mM PD (p44/42 MAPK kinase inhibitor), or
vehicle (DMSO) alone for 48 h.
2.2. Targeted disruption of Brd4 gene in mice
Brd4 heterozygous allele (Brd4þ /) mice were generated by our
group in an NIH animal facility. The mice were derived from C57BL/
6J mice and bred with wild-type mice purchased from Japan Or-
iental Yeast Co. Ltd. (Shizuoka, Japan). Brd4þ / mice were divided
into four groups analyzed at the following times after birth: 10 days
(n¼20 mice; control, 10; Brd4þ /–, 10), 14 days (n¼16 mice; control,
11; Brd4þ /–, 5), 21 days (n¼14 mice; control, 7; Brd4þ /–, 7), and 26
days (n¼17 mice; control, 9; Brd4þ /–, 8). Animals were genotyped
by polymerase chain reaction (PCR) using the following primers:
WT forward: 5′-GGACTAGAAACCTCCCAAATGTCTACAA-3′; neo for-
ward: 5′-TGAAGAGCTTGGCGGCGAATGGG-3′; both reverse: 5′-
CCTGTGTGCACTTGCTCCCGAGGAGAGA-3′. The PCR conditions for
WT were 94 °C for 1 min, and 34 cycles of 94 °C for 20 s, 60 °C for
20 s, and 72 °C for 2 min, and 72 °C for 7 min. The real-time reverse
transcription (RT)-PCR conditions for neo were 95 °C for 5 min, and
30 cycles of 95 °C for 10 s, 60 °C for 10 s, and 72 °C for 1 min 30 s,
and 95 °C for 10 s, 65 °C for 15 s, and 50 °C for 10 s. Mice were
maintained in an air-conditioned room at 2372 °C and a humidity
of 5575% with a 12-h light–dark cycle (7:00–19:00) at the Japan
Oriental Yeast Co. Ltd. Mice were killed by decapitation between
12:00 and 15:00. All experimental procedures were approved by
the Institutional Animal Care and Use Committee of the University
of Shizuoka.
2.3. RNA analysis
Total RNA was subjected to RT using Superscript III reverse
transcriptase (Invitrogen). Test genes (Caco-2 cells: SLC2A5; mice:
Slc2a5, Si, and Brd4) and housekeeping genes (Caco-2 cells: β-actin
[ACTB], mice: 16 S rRNA) were ampliﬁed by real-time RT-PCR using
a Light Cycler System (Roche Molecular Biochemicals, Bavaria,
Germany) and SYBR Green I (Takara Bio, Shiga, Japan). The cycle
threshold (CT) values detected by real-time RT-PCR were con-
verted into signal intensities using the delta-delta method [15].
The sequences of the primers for real-time RT-PCR are listed in
Supplemental Table 1.
2.4. Immunoblotting
Total cell proteins were extracted in RIPA buffer (1% Nonidet
P-40, 0.1% sodium dodecyl sulfate [SDS], 20 mM Tris–HCl pH 8.0,
5 mM ethylenediamine tetraacetic acid, 150 mM NaCl, protease
inhibitor tablet (Complete Mini, Roche Molecular Biochemicals)/
10 ml, and phosphatase inhibitors [1 mM NaMoO4, 50 mM NaF,
and 1 mM Na3VO4]). Lysates were centrifuged at 10,000g for
10 min at 4 °C. The protein concentration of the soluble super-
natants was determined by the Lowry method, and samples were
stored at 20 °C.
Total proteins (60 μg, Fig. 1A; 70 μg, Fig. 2A) were separated by
10% SDS–polyacrylamide gel electrophoresis and transferred to
Immobilon membranes (Millipore; Billerica, MA, USA) at 80 V for
120 min in Tris/glycine/methanol transfer buffer. The membranes
Fig. 1. Expression of SLC2A5 in Caco-2 cells treated with Dex and/or PD. (A) SLC2A5mRNA in cells treated with Dex and/or PD for 8, 24, or 48 h, and protein levels of SLC2A5,
Brd4, Cyclin T1, Cdk9, and TFIIB in cells treated with Dex and/or PD for 48 h. (B) ChIP assays for acetylated histone H3 at K9/14, acetylated histone H4 at K5/8/12/16, Brd4,
Cdk9, and Pol II around the SLC2A5 gene in cells treated with Dex and/or PD for 48 h. Means7SEM of six (RNA) or ﬁve (ChIP assays) experiments are shown. *P o0.05 and
**P o0.01 compared with control cells (DMSO).
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saline (PBS) with 0.05% Tween 20, pH 7.4 (PBS–Tween) at room
temperature. The membranes were then incubated in 3% skim milk
in PBS–Tween at 4 °C for 47 h with primary antibodies against
Brd4 [16], cyclin T1 (Abcam, Cambridge, MA, USA), Cdk9 (Santa Cruz
Biotechnology; Santa Cruz, CA, USA), and TFIIB (Santa Cruz Bio-
technology). After washing in PBS–Tween, the membranes were
incubated with biotin-conjugated anti-rabbit IgG (GE Healthcare,
Little Chalfont, UK) in 3% PBS–Tween. The membranes were then
washed in PBS–Tween and incubated with horseradish peroxidase-
conjugated anti-biotin third antibody (Cell Signaling Technology,
MA, USA). Signals were detected by chemiluminescence (ECL Plus,
GE Healthcare), according to the manufacturer's instructions.2.5. Chromatin immunoprecipitation (ChIP) assay
Cells were incubated in ﬁxation solution (1% formaldehyde,
4.5 mM HEPES pH 8.0, 9 mM NaCl, 0.09 mM EDTA, 0.04 mM
ethylene glycol tetraacetic acid) in 10% FCS/DMEM for 30 min at
37 °C. Reactions were terminated by adding glycine to a ﬁnal
concentration of 150 mM. After washing in ﬂuorescence-activated
cell sorting solution (1 PBS, 2% bovine serum, 0.05% NaN3), the
samples were sonicated in SDS lysis buffer (50 mM Tris–HCl pH
8.0, 10 mM EDTA pH 8.0, 1% SDS, 0.5 mM phenylmethanesulfo-
nylﬂuoride) to generate DNA fragments of 200–500 bp. The ChIP
assay was performed as described previously [16], using 1 μg an-
tibodies against acetyl histone H3 at K9/14 (Millipore), acetyl
histone H4 at K5/8/12/16 (Millipore), Brd4 (custom antibody
generated by the Sigma Custom Antibody service using the Brd4C-
terminal peptide CFQSDLLSIFEENLF), Cdk9 (Santa Cruz
Fig. 2. SLC2A5 mRNA expression in Dex and/or PD-treated Brd4-depleted cells.
Protein levels of SLC2A5, Brd4, Cyclin T1, Cdk9, and TFIIB (A) and SLC2A5 mRNA
(B) in cells treated with Dex and/or PD for 48 h. Means7SEM of six mRNA de-
terminations are shown. *P o0.05 and **P o0.01 compared with control cells
(DMSO). ##P o0.01 compared with control cells.
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USA), or normal rabbit IgG. The precipitated DNA was subjected to
real-time PCR using primers corresponding to the indicated sites
in the promoter/enhancer and transcribed regions. The CT values
of the ChIP signals detected by real-time PCR were converted to
percentages of the signal for the input DNA using the delta-delta
method [15], with the formula 100 [2(CT input–CT IP sample)]. The
primer sequences used in ChIP assays are listed in Supplemental
Table 1.
2.6. Statistical analysis
Results were expressed as mean7standard error of the mean
(SEM). The signiﬁcance of differences among groups was de-
termined by Tukey's multiple range test based on one-way ana-
lysis of variance (ANOVA) (Fig. 1), two-way ANOVA (Figs. 2 and 3),
or Student's t-test (Fig. 4). A P value o0.05 was considered sta-
tistically signiﬁcant.3. Results
3.1. Co-treatment with Dex and PD enhances SLC2A5 mRNA and
binding of acetylated histones and Brd4–P-TEFb–Pol II around the
SLC2A5 gene in Caco-2 cells
We performed real-time RT-PCR and ChIP assays in Caco-2 cellstreated with 1 mM Dex, an agonist for glucocorticoid receptor, with
or without 50 mM PD, a p44/42 MAPK inhibitor. SLC2A5 expression
was signiﬁcantly increased by co-treatment with Dex and PD for 8,
24, and 48 h, and SLC2A5 protein levels were signiﬁcantly elevated
by co-treatment with Dex and PD for 48 h. Brd4, Cyclin T1, Cdk9,
and TFIIB were expressed in Caco-2 cells treated with DMSO, Dex,
PD, or Dex and PD. However, Brd4 protein levels were decreased
by PD or co-treatment with Dex plus PD (Fig. 1A).
All ChIP signals for IgG were o0.02% relative to input signals.
ChIP signals from upstream/transcribed regions associated with
acetylated H3 (K9/14) were markedly enhanced by co-treatment
with Dex and PD for 48 h, particularly the transcribed regions of
SLC2A5 at 5100 bp and from 1000 bp to 2000 bp. Signals
throughout the upstream/transcribed region of SLC2A5 associated
with acetylated histone H4 (K5/8/12/16) were slightly enhanced by
co-treatment with Dex and PD for 48 h, and signals from 2000 bp
of SLC2A5 were signiﬁcantly higher. Co-treatment also notably
increased the ChIP signals associated with Brd4 on the promoter/
enhancer region and the transcribed region close to the initiation
site of SLC2A5 from 2000 bp to 1000 bp. Co-treatment with Dex
and PD for 48 h strongly increased the ChIP signals associated with
Cdk9 on the transcribed region close to the initiation site of SLC2A5
at 1000 bp and 22,000 bp. ChIP signals were also signiﬁcantly in-
creased in association with Pol II on the promoter/enhancer region
and the transcribed region close to the initiation site of SLC2A5 at
2000 bp, 1 bp, and 1000 bp (Fig. 1B).
3.2. Effects of Brd4 depletion on SLC2A5 expression and binding of
acetylated histones and Brd4–P-TEFb–Pol II around the SLC2A5 gene
in Caco-2 cells co-treated with Dex and PD
We generated Caco-2 cell lines stably expressing Brd4 shRNA to
determine if Brd4 was necessary for the induction of SLC2A5 in
Caco-2 cells co-treated with Dex and PD. Brd4 protein levels were
reduced in these cells compared with controls. Levels of Cyclin T1,
Cdk9, and TFIIB proteins were similar in cells subjected to different
treatments in both control- and Brd4-shRNA-expressing cells. In
contrast, co-treatment with Dex and PD for 48 h increased SLC2A5
levels in control cells, but not in Brd4-shRNA-expressing cells
(Fig. 2A). We obtained similar results for SLC2A5mRNA levels, with
a signiﬁcant difference between co-treated control- and Brd4-
shRNA-expressing cells (Fig. 2B).
Acetylation of histone H3 K9/14 on the promoter/enhancer and
transcribed regions of SLC2A5 (control: from 5100 bp to
2000 bp; Brd4 shRNA: from 5100 bp to 30,900 bp) increased
after co-treatment with Dex and PD for 48 h in both control- and
Brd4-shRNA-expressing cells (Fig. 4B). Acetylation of histone H4
K5/8/12/16 on the promoter/enhancer and transcribed regions of
SLC2A5 (control: from 5100 bp to 30,900 bp; Brd4 shRNA: from
5100 bp to 2000 bp) also increased after co-treatment with Dex
and PD in both cell lines. We obtained similar results in terms of
the associations of Brd4, Cdk9, and Pol II with SLC2A5 in control
cells and in WT cells in Fig. 1. However, this association was sig-
niﬁcantly reduced in Brd4-depleted cells (Fig. 3).
3.3. Effects of Brd4 depletion on small-intestine Slc2a5 gene ex-
pression during postnatal development in mice
We determined if Brd4 regulated the expression of Slc2a5 in the
mouse small intestine by real-time RT-PCR using total RNA ex-
tracted from WT or Brd4þ / mice at 10, 14, 21, and 26 days after
birth. The genetic background of Brd4 heterozygous (Brd4þ /)
mice is shown in Fig. 4. This covered the suckling–weaning tran-
sition period when serum glucocorticoid levels increase and p44/
42 MAPK is inactivated in rodents. Body weight was lower in
Brd4þ / mice compared with WT mice at each day after birth. We
Fig. 3. Binding of acetylated histone- and chromatin-remodeling factors around SLC2A5 in Brd4-depleted cells. ChIP assays for acetylated histone H3 at K9/14, acetylated
histone H4 at K5/8/12/16, Brd4, Cdk9, and Pol II around the SLC2A5 gene in control-shRNA- and Brd4-shRNA-expressing cells treated with Dex and/or PD for 48 h.
Means7SEM of ﬁve experiments are shown. *P o0.05 and **P o0.01 compared with control cells (DMSO). #P o0.05 and ##P o0.01 compared with control cells.
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mice compared with WT mice. Slc2a5, but not Si expression was
also signiﬁcantly lower in Brd4þ / mice compared with WT mice
at 21 and 26 days after birth (Fig. 4.).4. Discussion
In this study, we demonstrated that co-treatment with Dex and
PD induced SLC2A5 expression as well as acetylation of histones
around the SLC2A5 gene in Caco-2 cells. Furthermore, co-treat-
ment with Dex and PD also promoted the association of Brd4
around SLC2A5. Notably, although Brd4 protein levels were re-
duced by PD and co-treatment with PD and Dex, Brd4 binding
around SLC2A5 was strongly enhanced by co-treatment with PD
and Dex. Furthermore, we demonstrated that co-treatment withDex and PD promoted the association of P-TEFb and Pol II on the
transcribed region close to the transcription initiation site of
SLC2A5 in Caco-2 cells. These results were conﬁrmed by RNA in-
terference, which showed that these associations and the ex-
pression of SLC2A5 were Brd4-dependent. Recent studies have also
suggested that Brd4 recruits the P-TEFb mRNA transcription
elongation factor (Cyclin T1–Cdk9 complex), which regulates
mRNA transcription elongation by regulating Pol II activity [11].
Our results thus suggest that binding of Brd4 to the transcribed
region of SLC2A5 may enhance gene expression by recruiting
P-TEFb and Pol II to the acetylated histones in the transcribed re-
gion, thus enhancing mRNA transcription elongation.
SLC2A5 is induced in the small intestine of rodents during the
suckling–weaning transition period when serum glucocorticoid
levels increase and p44/42 MAPK is inactivated. Interestingly, we
found that small-intestine expression of Slc2a5 was signiﬁcantly
Fig. 4. Effects of Brd4 deﬁciency on mouse small-intestine SLC2A5 expression during the suckling–weaning period. (A) Mice were genotyped by PCR using DNA isolated from
the tail. Body weights (B), mRNA levels for Brd4 (C), Slc2a5 (D), and Si (E) in control and Brd4þ / mice at 10, 14, 21, and 26 days after birth. Numbers of X-axis in (B)–
(E) indicate days after birth of mice. Means7SEM for between ﬁve and 11 samples are shown. *P o0.05 and **P o0.01 compared with control mice.
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after birth, suggesting that Brd4 regulates the induction of small-
intestine Slc2a5 expression during the suckling–weaning transi-
tion in mice. It should be noted that body weight was lower in
Brd4þ / mice compared with WT mice, and the lower Slc2a5
mRNA levels in Brd4þ / mice may thus be associated with delayed
growth. However, mRNA levels of another intestinal gene, Si, were
similar in Brd4þ / and WT mice, implying that the decreasedSlc2a5 mRNA levels in Brd4þ / mice were likely related to re-
duction of Brd4 as a result of gene targeting, rather than delayed
growth. Further studies are needed to determine if acetylated
histone-Brd4–P-TEFb is recruited to the transcribed region of rat
jejunal Slc2a5 during the suckling–weaning transition.
We previously demonstrated that both GR translocation from
the cytosol to the nucleus, and GR binding to the promoter/en-
hancer region of SLC2A5 were enhanced by co-treatment with Dex
Y. Inamochi et al. / Biochemistry and Biophysics Reports 7 (2016) 150–156156and PD in Caco-2 cells [6]. These and the current results suggest
that Brd4–P-TEFb may enhance the rate of mRNA synthesis asso-
ciated with triggering of the transcription initiation reaction by GR
binding. Both transcription initiation and transcription elongation
may thus be important for mRNA production of functional genes.
However, expression of the Si gene during the suckling–weaning
transition in mice may not be affected by Brd4 reduction via gene
targeting. It is possible that the rates of expression of several genes
are controlled by Brd4-associated transcription elongation and/or
transcription initiation, while other genes may be controlled by
Brd4. This issue should be examined in future studies.
It is still unclear which cascade promotes Brd4–P-TEFb re-
cruitment to the transcribed region of SLC2A5. Because the en-
hancement of histone acetylation around SLC2A5 by co-treatment
with Dex and PD was closely associated with Brd4–P-TEFb binding,
co-treatment may enhance histone acetylation, which may in turn
promote Brd4–P-TEFb recruitment. However, the speciﬁc histone
acetyltransferase (HAT) that regulates histone acetylation around
SLC2A5 has not yet been identiﬁed. GCN5 is a HAT that controls
amino acid synthesis and is recruited around the transcription
initiation site of intestinal genes such as Si and Slc5a1 in response
to a high-carbohydrate diet in rats [17]. Given that GCN5 enhances
the mRNA transcriptional elongation step by acetylating histones
around the transcribed region [18], it may also contribute to the
induction of SLC2A5. A high-carbohydrate diet has also been
shown to promote the association of another HAT, CREB-binding
protein (CBP), with the Mgam gene, leading to increased Mgam
expression in mice [19]. HATs, including GCN5 and CBP, may thus
be involved in the observed regulation of SLC2A5 expression.
However, although many HATs have been identiﬁed [20], the
speciﬁc HAT that is activated by Dex and PD remains unknown and
should be investigated in future studies.
In conclusion, we demonstrated that Brd4 enhances the in-
duction of SLC2A5 in human intestinal Caco-2 cells after co-treat-
ment with a glucocorticoid hormone agonist and a MAPK in-
hibitor. This induction is mediated by recruiting P-TEFb to the
transcribed region and enhancing mRNA polymerase II transcrip-
tion elongation. We further demonstrated that Brd4 regulated the
induction of Slc2a5 in the small intestine during the suckling–
weaning transition in mice. These results suggest that Brd4–P-TEFb
plays a crucial role in differentiation-associated transcription of
SLC2A5 gene in intestinal Caco-2 cells and in the small intestine of
mice during weaning period.Author contributions
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